Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19.6M
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
-146K
-
Total reported value, excl. options
-
$2.51B
-
Value change
-
-$20.6M
-
Put/Call ratio
-
0.26
-
Number of buys
-
91
-
Number of sells
-
-91
-
Price
-
$154.46
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2021
236 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q4 2021.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 19.6M outstanding shares and own 82.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.74M shares), VANGUARD GROUP INC (1.72M shares), JANUS HENDERSON GROUP PLC (1.44M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.4M shares), STATE STREET CORP (887K shares), MACQUARIE GROUP LTD (625K shares), VILLERE ST DENIS J & CO LLC (519K shares), Chicago Capital, LLC (436K shares), Stephens Investment Management Group LLC (411K shares), and DIMENSIONAL FUND ADVISORS LP (373K shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.